• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Newsletters » The Carlat Psychiatry Report
psychiatry-report-header.png

The Carlat Psychiatry Report

Deprescribing (November/December) | 2024

View Archived Issues

Learning Objectives, Deprescribing, TCPR, November/December 2024

November 1, 2024

After reading these articles, you should be able to…

Read More

Vyvanse Goes Generic: An Amphetamine Apart

November 1, 2024
David Liebers, MD and Chris Aiken, MD

Known for lower misuse potential and a smoother effect profile, lisdexamfetamine stands out in ADHD treatment. This article explores what makes it unique among stimulants. 

Read More

Azstarys: Vyvanse’s Dexmethylphenidate Cousin

November 1, 2024
Chris Aiken, MD

Azstarys is methylphenidate's answer to Vyvanse. But how does its abuse potential compare?

Read More

How to Stop a Psychiatric Med

November 1, 2024
Mark Horowitz, MBBS, PhD

Dr. Horowitz explains the principle, practicalities, and science of tapering psychiatric medications. 

Read More

Antipsychotics Reconsidered

November 1, 2024
Harish Kavirajan, MD

Harish Kavirajan revisits the use of antipsychotics in depression, weighing small benefits against serious risks, like tardive dyskinesia and metabolic issues. 

Read More

Esketamine vs Quetiapine in ­Treatment-Resistant Depression

November 1, 2024
Ivy Song, MD

Esketamine outperforms quetiapine in TRD remission rates, but the clinical significance of this difference remains uncertain.

Read More

Lithium, Valproate Have Low (and Similar) Risk of Kidney Injury

November 1, 2024
Alex Evans, PharmD, MBA.

Research explores the kidney injury risks associated with lithium compared to valproate, revealing unexpected findings.

Read More

Overdiagnosis of ADHD

November 1, 2024
Alvin Marquez, MD

A recent study reveals the limitations of ADHD screening tools, highlighting the risks of overdiagnosis in adults based on self-reports.

Read More

Estrogen in Schizophrenia

November 1, 2024
Sarah Azarchi, MD

Estrogen therapy may improve schizophrenia symptoms in women, highlighting its potential role as an adjunctive treatment.

Read More

CME Post-Test, Deprescribing, TCPR, November/December 2024

November 1, 2024

By successfully completing the test you will be awarded a certificate for 2 CME credit.

Read More
SUBSCRIBE NOW
DOWNLOAD NOW
Editor-in-Chief
Aiken.png
Chris Aiken, MD
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.

Full Editorial Information
Featured Book
  • MFB7e_Print_App_Access.png

    Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

    The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.